Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Vivos Inc. D/B/A Advanced Medical Isotope Corporation has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 examiner and 1 art unit.
CABRAL, ROBERT S is the busiest examiner, with 1 pending matter. The listed prosecution activity is concentrated in one assignment, allowing counsel to focus directly on the examiner's requirements and the applicable technical group.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CABRAL, ROBERT S | 1 | 62.8% | +32.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18974143 | RADIOTHERAPY GEL AND METHOD OF PREPARING THE SAME | CABRAL, ROBERT S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18974143 | RADIOTHERAPY GEL AND METHOD OF PREPARING THE SAME | CABRAL, ROBERT S | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18974143 | RADIOTHERAPY GEL AND METHOD OF PREPARING THE SAME | CABRAL, ROBERT S | 1614 | §101§102§103DP | Non-Final OA | — | Pending | Dec 09, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVivos Inc. D/B/A Advanced Medical Isotope Corporation has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Robert S Cabral has the most, with 1 of Vivos Inc. D/B/A Advanced Medical Isotope Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
